Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Need ways to save money in your budget fast? Check out these quick tips to help you maximize your savings in no time.
20,742 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
July markets bring attention to enduring brands and steady income. Coca-Cola's blend of dividend discipline, pricing ...
FactSet (FDS) investors are eyeing the Q3 2026 earnings with questions about growth, margins, and product strategy. T...
Constellation Energy trades below $290, prompting questions about value and risk. This guide breaks down the fundamen...
Today’s trading session spotlighted PayPal as takeover rumors circulated, lifting the stock while the broader market ...
Sunrun’s stock tumbled on a day of mixed signals: strong quarterly revenue but cautious guidance for 2026. This artic...
A fresh take on a notable portfolio move: Kettle Hill Capital reveals a sizable Braze stake via a 747,715-share initi...
A regional bank stock year delivered a solid 14% gain even as a large investor trimmed holdings by roughly $2.6 milli...
A major industrial player signals confidence with a $4.3 million stake move. This analysis explains what worthington ...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
As 2026 unfolds, investors are weighing which bank stocks offer durable growth and solid risk controls. This guide br...